These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A new anti-inflammatory-analgesic-antipyretic, morniflumate, in the treatment of chronic recurring bronchitis]. Melica A, Donateo L, Gerardi R, Parenti M. Riv Eur Sci Med Farmacol; 1991; 13(1-2):51-60. PubMed ID: 1796197 [Abstract] [Full Text] [Related]
3. The effect of Donalgin on locomotor disease. Abrányi I, Papp I. Ther Hung; 1977; 25(1):20-3. PubMed ID: 854866 [No Abstract] [Full Text] [Related]
4. Examinations with Donalgin in locomotor diseases treated at the out-patient department. Kovács E. Ther Hung; 1977; 25(2):75-8. PubMed ID: 302503 [No Abstract] [Full Text] [Related]
5. Clinical effectivity of Donalgin--niflumic acid--in locomotor diseases. Krakovits G, Tallián A, Képes P. Ther Hung; 1981; 29(2):77-85. PubMed ID: 6765143 [No Abstract] [Full Text] [Related]
6. [Treatment of acute inflammatory pathology of the upper airway with morniflumate]. Marchioni CF, Livi E, Oliani C, Guerzoni P, Corona M. Riv Eur Sci Med Farmacol; 1990 Dec; 12(6):347-57. PubMed ID: 2132289 [Abstract] [Full Text] [Related]
7. [Effect of niflumic acid on chronic rheumatoid arthritis]. Shichikawa K, Onoda T. Ryumachi; 1976 May; 16(2):199-211. PubMed ID: 785616 [No Abstract] [Full Text] [Related]
11. Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation. Cremonesi G, Cavalieri L. J Int Med Res; 2015 Jun; 43(3):290-302. PubMed ID: 25921871 [Abstract] [Full Text] [Related]